Last Updated: April 29, 2026

CLINICAL TRIALS PROFILE FOR VOSPIRE ER

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Vospire Er

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00550550 ↗	Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)	Completed	ALK-Abelló A/S	Phase 3	2007-11-01	The purpose of the study is to investigate the efficacy and safety of a grass sublingual tablet in children and adolescents with a history of grass-pollen induced rhinoconjunctivitis with or without asthma.
NCT00550550 ↗	Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2007-11-01	The purpose of the study is to investigate the efficacy and safety of a grass sublingual tablet in children and adolescents with a history of grass-pollen induced rhinoconjunctivitis with or without asthma.
NCT00562159 ↗	Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)	Completed	ALK-Abelló A/S	Phase 3	2007-11-01	This purpose of this study is to determine the efficacy and safety of a grass sublingual (under-the-tongue) tablet.
NCT00562159 ↗	Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2007-11-01	This purpose of this study is to determine the efficacy and safety of a grass sublingual (under-the-tongue) tablet.
NCT00649779 ↗	Fasting Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg	Completed	Mylan Pharmaceuticals	Phase 1	2005-09-01	The objective of this study was to investigate the bioequivalence of Mylan's albuterol sulfate extended-release 8 mg tablets to Pliva's VoSpire™ ER 8 mg tablets following a single, oral 8 mg (1 x 8 mg) dose administered under fasting conditions.
NCT00649987 ↗	Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg	Completed	Mylan Pharmaceuticals	Phase 1	2005-09-01	The objective of this study was to investigate the bioequivalence of Mylan's albuterol sulfate extended-release 8 mg tablets to Pliva's VoSpire™ ER 8 mg tablets following a single, oral 8 mg (1 x 8 mg) dose administered under fed conditions.
NCT01851642 ↗	Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs	Recruiting	University of Florida		2007-09-01	The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Vospire Er

Condition Name

Chart
Table

Condition Name for Vospire Er
Intervention	Trials
Rhinoconjunctivitis	2
Allergy	2
Conjunctivitis	2
Healthy	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Vospire Er
Intervention	Trials
Rhinitis	2
Conjunctivitis	2
Spinal Cord Injuries	1
Paresis	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Vospire Er

Trials by Country

Map
Table

Trials by Country for Vospire Er
Location	Trials
United States	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Vospire Er
Location	Trials
North Dakota	2
New York	1
Florida	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Vospire Er

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Vospire Er
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	2
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Vospire Er
Clinical Trial Phase	Trials
Completed	4
Active, not recruiting	1
Recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Vospire Er

Sponsor Name

Chart
Table

Sponsor Name for Vospire Er
Sponsor	Trials
ALK-Abelló A/S	2
Merck Sharp & Dohme Corp.	2
Mylan Pharmaceuticals	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Vospire Er
Sponsor	Trials
Industry	6
Other	1
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.